Skip to main content
OpenTrials

Clinical trial condition

Carbohydrate Metabolism, Inborn Errors

Explore clinical trials studying Carbohydrate Metabolism, Inborn Errors. Study availability and eligibility vary by location and protocol.

544 public trials 96 recruiting studies
Refine in advanced search Browse all conditions

Carbohydrate Metabolism, Inborn Errors trial results

Completed

High Dose or High Dose Frequency Study of Alglucosidase Alfa

NCT00483379

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +15 more
Locations
  • Birmingham, Alabama, United States
  • Stanford, California, United States
  • Washington D.C., District of Columbia, United States
  • Chicago, Illinois, United States
View Trial Details
Completed

Expanded Access Use of Myozyme (Alglucosidase Alfa) in Patients With Late-onset Pompe Disease

NCT00074932

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +13 more
Locations
  • Colorado Health Science Center Aurora, Colorado, United States
  • Galichia Heart Hospital Wichita, Kansas, United States
  • Genzyme Medical Information Cambridge, Massachusetts, United States
  • Freeman Health Systems Joplin, Missouri, United States
View Trial Details
Completed

Extension Study of Patients With Infantile-Onset Pompe Disease Who Were Previously Enrolled in Protocol AGLU01602

NCT00125879

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +12 more
Locations
  • University of Alabama Birmingham, Alabama, United States
  • Shands Hospital at the University of Florida Gainesville, Florida, United States
  • Miami Children's Hospital Miami, Florida, United States
  • Emory University Medical Genetics Decatur, Georgia, United States
View all 14 locations
View Trial Details
Completed

rhGAA in Patients With Infantile-onset Glycogen Storage Disease-II (Pompe Disease)

NCT00053573

Conditions
Acid Maltase Deficiency Disease, Brain Diseases, Brain Diseases, Metabolic, +15 more
Locations
  • University of Florida College of Medicine Gainesville, Florida, United States
  • Duke University Medical Center Durham, North Carolina, United States
  • Children's Hospital Medical Center Cincinnati, Ohio, United States
  • Pediatrique Hopital de Brousse Lyon, France
View Trial Details
Completed

Extension Study of Long-term Safety and Efficacy of Myozyme in Patients With Pompe Disease Who Were Previously Enrolled in Genzyme Sponsored Enzyme Replacement Therapy (ERT) Studies

NCT00763932

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +13 more
Locations
  • Children's Hospital of Oakland Oakland, California, United States
  • Children's Hospital of Orange Country Orange, California, United States
  • University of Nebraska Medical Center Omaha, Nebraska, United States
  • Institute for Genetic Medicine, Saint Peter's University Hospital New Brunswick, New Jersey, United States
View Trial Details
Completed

A Study of the Safety and Efficacy of rhGAA in Patients With Infantile-onset Pompe Disease

NCT00059280

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +12 more
Locations
  • University of Florida College of Medicine Gainesville, Florida, United States
  • Duke University Medical Center Durham, North Carolina, United States
  • Children's Hospital Medical Center Cincinnati, Ohio, United States
  • University of Utah Medical Center Salt Lake City, Utah, United States
View Trial Details

Related conditions